דלג לתוכן הראשי
Yamanaka Factors

"Partial Reprogramming" Offers Hope for Slowing Aging

Aging is a complex and multifaceted process, involving many changes at the molecular, cellular, tissue, and organ levels. As a result, older cells lose their ability to function optimally, leading to a decline in body function and an increase in the incidence of diseases. Reprogramming is an innovative therapeutic approach aimed at reversing the aging process by returning aged cells to a younger state...

📅10/04/2024 🔄עודכן 07/05/2026 ⏱️5 דקות קריאה ✍️Reverse Aging 👁️856 צפיות

Aging is a complex and multifaceted process, involving many changes at the molecular, cellular, tissue, and organ levels.
As a result, older cells lose their ability to function optimally, leading to a decline in body function and an increase in the incidence of diseases.

Reprogramming is an innovative therapeutic approach aimed at reversing the aging process by returning aged cells to a younger state.
This approach is based on the re-expression of Yamanaka factors,
a group of genes central to converting somatic cells into iPS cells (induced pluripotent stem cells).

Partial reprogramming is a new and evolving version of this approach.
Unlike full reprogramming, which leads to the conversion of somatic cells into iPS cells,
partial reprogramming causes more defined changes in the cell while preserving its identity.
This approach may be more effective and safer, opening new possibilities for treating aging and age-related diseases.

Innovative research recently published in the journal eLife demonstrates the great potential of partial reprogramming.
A team of researchers from the University of California, Berkeley, led by Wayne Mitchell, Ludger Gumina, Alexander Tyshkovsky, and their team,
examined the effects of partial reprogramming on aged cells.

This study used a variety of advanced methods to examine the effects of partial reprogramming on aged cells:

1. Partial Reprogramming:

  • The researchers used a cocktail of known small molecules, specifically designed to induce partial reprogramming.
  • These compounds cause temporary expression of Yamanaka factors, a group of genes central to converting somatic cells into iPS cells.
  • This temporary expression allows achieving desired changes in the cell while avoiding its full conversion into an iPS cell.

2. Fibroblasts:

  • The study focused on fibroblasts, cells found in connective tissues.
  • These cells were chosen because they are relatively easy to grow in the lab and can yield accurate results.
  • Another advantage is that fibroblasts are relevant to a variety of age-related diseases.

3. Comprehensive Molecular Analyses:

  • After performing partial reprogramming, the researchers analyzed the cells at different levels:
    • RNA-seq: Analysis of the cells' RNA sequences, allowing identification of changes in gene expression.
    • ChIP-seq: Analysis of transcription factor binding sites on DNA, enabling understanding of gene expression control mechanisms.
    • Proteomics: Analysis of proteins, allowing identification of changes in protein levels and function.

4. Additional Metrics:

  • In addition to molecular analyses, functional metrics were also measured, such as:
    • Cellular respiration: A measure of mitochondrial function, cellular organelles essential for energy production.
    • Mitochondrial membrane potential: Another measure of mitochondrial function.

5. Comparison Between Young and Aged Cells:

  • The study included a comparison between results obtained from young cells and aged cells that underwent partial reprogramming.
  • This comparison allowed assessing the treatment's effectiveness in restoring normal function to aged cells.

Advantages of the Research Methods:

  • Use of advanced and precise technologies.
  • In-depth analysis at different levels, from the genome to proteins.
  • Examination of functional metrics.
  • Comparison between young and aged cells.

Research Results:

The partial reprogramming treatment caused significant changes in a variety of metrics, both at the transcript and protein levels:

1. Changes at the Transcript Level:

  • RNA-seq analysis showed changes in the expression of thousands of genes.
  • The main changes were related to increased expression of genes associated with metabolic processes, especially those related to mitochondria.

2. Changes at the Protein Level:

  • Proteomics analysis showed changes in the levels and function of hundreds of proteins.
  • Again, the main changes were related to increased activity of proteins involved in mitochondrial metabolic processes.

3. Functional Effects:

  • Partial reprogramming caused a significant improvement in cellular function, as seen in changes in cellular respiration and mitochondrial membrane potential.
  • As a result, the biological age of the aged cells was significantly reduced.

4. Comparison Between Young and Aged Cells:

  • Partial reprogramming was more effective in aged cells compared to young cells.
  • This result suggests that the treatment may be more effective in slowing the aging process than in restoring normal function to young cells.

Conclusions:

This study demonstrates the great potential of partial reprogramming as an innovative treatment for aging.
These approaches may lead to the development of new drugs and more effective treatments for a variety of age-related diseases, such as cardiovascular diseases, Alzheimer's, and cancer.

.
References:
https://elifesciences.org/articles/90579

💬 תגובות (0)

תגובות אנונימיות מוצגות לאחר אישור.

היו הראשונים להגיב על המאמר.